CO5160255A1 - DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO[4,5-b]INDOL-1- CARBOXAMIDA Y COMPOSICIONES QUE LOS COMPRENDEN - Google Patents

DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO[4,5-b]INDOL-1- CARBOXAMIDA Y COMPOSICIONES QUE LOS COMPRENDEN

Info

Publication number
CO5160255A1
CO5160255A1 CO00003864A CO00003864A CO5160255A1 CO 5160255 A1 CO5160255 A1 CO 5160255A1 CO 00003864 A CO00003864 A CO 00003864A CO 00003864 A CO00003864 A CO 00003864A CO 5160255 A1 CO5160255 A1 CO 5160255A1
Authority
CO
Colombia
Prior art keywords
piridazino
dihidro
indol
carboxamide
oxo
Prior art date
Application number
CO00003864A
Other languages
English (en)
Inventor
Frank Marguet
Jacques Froissant
Regine Bartsch-Li
Benoit Marabout
Mireille Sevrin
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of CO5160255A1 publication Critical patent/CO5160255A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Compuesto que responde a la fórmula general (I):<EMI FILE="00003864_1" ID="1" IMF=JPEG >en la cualX representa un átomo de hidrógeno o de halógeno,Y representa uno o varios átomos o grupos elegidos entre el hidrógeno, los halógenos y los grupos metilo, metoxi y nitro, R1 representa un grupo (C1-C4)alquilo,R2 y R3 representan cada uno, independientemente del otro, un átomo de hidrógeno, un grupo (C1-C4)alquilo o bien R2 y R3 forman con el átomo de nitrógeno que los lleva, un grupo pirrolidinilo, piperidinilo o morfolinilo.
CO00003864A 1999-01-26 2000-01-25 DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO[4,5-b]INDOL-1- CARBOXAMIDA Y COMPOSICIONES QUE LOS COMPRENDEN CO5160255A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9900805A FR2788776B1 (fr) 1999-01-26 1999-01-26 Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
CO5160255A1 true CO5160255A1 (es) 2002-05-30

Family

ID=9541211

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00003864A CO5160255A1 (es) 1999-01-26 2000-01-25 DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO[4,5-b]INDOL-1- CARBOXAMIDA Y COMPOSICIONES QUE LOS COMPRENDEN

Country Status (11)

Country Link
US (1) US6451795B1 (es)
EP (1) EP1149101B1 (es)
JP (1) JP4574860B2 (es)
AR (1) AR030016A1 (es)
AT (1) ATE236905T1 (es)
AU (1) AU3057800A (es)
CO (1) CO5160255A1 (es)
DE (1) DE60002043T2 (es)
ES (1) ES2194696T3 (es)
FR (1) FR2788776B1 (es)
WO (1) WO2000044751A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788696B1 (fr) * 1999-01-26 2004-03-05 Synthelabo Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR2811990A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2833953B1 (fr) * 2001-12-21 2004-12-03 Sanofi Synthelabo DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2838124B1 (fr) * 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
GB0523506D0 (en) 2005-11-18 2005-12-28 Hammersmith Imanet Ltd Novel in vivo imaging compounds
GB0818738D0 (en) * 2008-10-13 2008-11-19 Ge Healthcare Ltd Imaging neuroflammation
GB0905328D0 (en) * 2009-03-27 2009-05-13 Ge Healthcare Ltd Indole derivatives
KR101886879B1 (ko) * 2010-03-26 2018-08-08 지이 헬쓰케어 리미티드 Ｐｂｒ 리간드로서의 트리시클릭 인돌 유도체
US9220795B2 (en) 2011-09-22 2015-12-29 Ge Healthcare Limited Indole derivatives
GB201312768D0 (en) 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9109972D0 (en) * 1991-05-09 1991-07-03 Ici Plc Therapeutic compounds
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
FR2766823B1 (fr) 1997-07-30 1999-10-08 Synthelabo Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
DE60002043D1 (de) 2003-05-15
US6451795B1 (en) 2002-09-17
WO2000044751A1 (fr) 2000-08-03
ES2194696T3 (es) 2003-12-01
FR2788776A1 (fr) 2000-07-28
JP4574860B2 (ja) 2010-11-04
AU3057800A (en) 2000-08-18
DE60002043T2 (de) 2004-02-19
AR030016A1 (es) 2003-08-13
ATE236905T1 (de) 2003-04-15
JP2002535406A (ja) 2002-10-22
EP1149101A1 (fr) 2001-10-31
EP1149101B1 (fr) 2003-04-09
FR2788776B1 (fr) 2001-02-23

Similar Documents

Publication Publication Date Title
CO5310534A1 (es) Nuevos derivados de androstano anti-inflamatorios
CO5570660A2 (es) Indazolilpirrolotriazinas c-6 modificadas
CO5690130A1 (es) Derivados de eter biarilico que presentan actividad como inhibidores de la recaptacion de monoaminas para el tratamiento del snc
CO5601018A2 (es) Derivados de n-fenil-2-pirimidin-amina
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
AR031597A1 (es) Compuestos piperidinos,un proceso para su preparacion, composiciones farmaceuticas,y el uso de dichos compuestos para la fabricacion de un medicamento para uso como inhibidores ccr-3
ECSP045369A (es) Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica
PA8621501A1 (es) Intermediarios de quinolina como inhibidores de receptores de tirosina quinasas y la síntesis de los mismos
SV1998000008A (es) Inhibisores de sulfamida-metaloproteasa. ref. ran 4070\114
AR010331A1 (es) Compuestos derivados de 6-fenilpiridil-2-amina utiles como inhibidores nos, composiciones farmaceuticas que comprenden dichos compuestos, y metodosde tratamiento utilizando dichos compuestos.
CO5320599A1 (es) Inhibidores no peptidilicos de la union a las celulas depen dientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
AR051467A1 (es) Derivados de aminopiridina con accion inhibitoria selectiva de la aurora quinasa a
AR006890A1 (es) Compuestos alquil-4-silil-fenoles y esteres de los mismos como agentes antiateroscleroticos
BR0316609A (pt) Sinomenina e compostos de sinomenina, sìntese e uso
CO5160255A1 (es) DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO[4,5-b]INDOL-1- CARBOXAMIDA Y COMPOSICIONES QUE LOS COMPRENDEN
CO5210883A1 (es) DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO [4,5,-b]INDOL- 1-ACETAMIDA
CO4900066A1 (es) Derivados de tetrahidroquinolina
CO5160242A1 (es) UTILIZACION DE DERIVADOS DE PIRIDAZINO [4,5-b] INDOL-1- ACETAMIDA, PARA LA PREPARACION DE MEDICAMENTOS DESTINADOS A LAS ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL
CO5380019A1 (es) Azalidas de 13 miembros utiles como agentes antibioticos
CO4950561A1 (es) Derivados de ergolina
CO5040004A1 (es) 2-4-diamino-1,3,5-triazinas, su preparacion y empleo como herbicidas y fitorreguladores
AR053559A1 (es) Compuestos derivados antibacterianos de 2,4&#39; -dihidroxifenilo 3&#39;,5-disustituidos y metodos relacionados
CO5130006A1 (es) Compuestos de pirazina
HUP9801386A2 (hu) Szerotonin 5-HT4 receptor parciális agonistáiként és antagonistáiként alkalmazható indazol-karboxamid-származékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
AR024747A1 (es) Derivados de aminotiazoles, su preparacion y las composiciones farmaceuticas que los contienen.